Pneumocystis carinii pneumonia in Hong Kong: A 10 year retrospective study

Journal of Medical Microbiology

Volumn 55, Issue 1, 2006, Pages 85-88

  Hui, M ^a   Kwok, W T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PENTAMIDINE; PREDNISOLONE; TRIMETHOPRIM; VINCRISTINE;

ADULT; AGED; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG TOLERABILITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; MALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SUPERINFECTION; T CELL LYMPHOMA; VOMITING;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HONG KONG; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 29744458325     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45893-0     Document Type: Review

References (23)

1. Arend, S. M., Kroon, F. P. & van't Wout, J. W. (1995). Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 155, 2436-2441.
2. Barry, S. M. & Johnson, M. A. (2001). Pneumocystis carinni pneumonia: a review of current issues in diagnosis and management. HIV Med 2, 123-132.
3. Cailliez, J. C., Seguy, N., Denis, C. M., Allouat, E. M., Mazars, E., Polonelli, L., Camus, D. & Dei-Cas, E. (1996). Pneumocystis carinii: an atypical fungal micro-organism. J Med Vet Mycol 34, 227-239.
4. Cunha, B. A. (2001). Pneumonias in the compromised host. Infect Dis Clin North Am 15, 591-612.
5. Gerrard, J. G. (1995). Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 162, 233-235.
6. Gordon, S. M., LaRosa, S. P., Kalmadi, S., Arrolgia, A. C., Avery, R. K., Truesdell-LaRosa, L. & Longworth, D. L. (1999). Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 28, 240-246.
7. Higgins, R. M., Bloom, S. L., Hopkin, J. M. & Morris, P. J. (1989). The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 47, 558-560.
8. Klein, N. C., Duncanson, F. P., Lenox, T. H. & other authors (1992). Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. AIDS 6, 301-305.
9. Klein, N. C., Go, C. H. & Cunha, B. A. (2001). Infections associated with steroid use. Infect Dis Clin North Am 15, 423-432.
10. Leung, T. F., Ng, P. C., Fok, T. F., Wong, M. C., Wong, W., Cheung, K. L & So, K. W. (2000). Pneumocystis carinii pneumonia in an immunocompetent infant with congenital cytomegalovirus infection. Infection 28, 184-186.
11. Li, K. C., Lai, S. S. & Lam, S. T. (1999). Adequacy and pitfalls of G6PD deficiency counseling in Hong Kong. Southeast Asian J Trop Med Public Health 30 (Suppl. 2), 79-83.
12. Montaner, J. S., Lawson, L. M., Levitt, N., Belzberg, A., Schechter, M. T. & Ruedy, J. (1990). Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 113, 14-20.
13. Olsen, S. L., Renlund, D. G., O'Connell, J. B., Taylor, D. O., Lassetter, J. E., Eastburn, T. E., Hammond, E. H. & Bristow, M. R. (1993). Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 56, 359-362.
14. Palella, F. J., Jr, Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J. & Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338, 853-860.
15. Phair, J., Munoz, A., Detels, R., Kaslow, R., Rinaldo, C. & Saah, A. (1990). The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. Multicenter AIDS Cohort Study Group. N Engl J Med 322, 161-165.
16. Roblot, F., Godet, C., Le Moal, G. & 9 other authors (2002). Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21, 523-531.
17. Saksasithon, S., Sungkanuparph, S. & Thanakitcharu, S. (2003). Pneumocystis carinii pneumonia in patients without HIV infection. J Med Assoc Thai 86, 612-616.
18. Schliep, T. C. & Yarrish, R. L. (1999). Pneumocystis carinii pneumonia. Semin Respir Infect 14, 333-343.
19. Sepkowitz, K. A. (2002). Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34, 1098-1107.
20. Stuck, A. E., Minder, C. E. & Frey, F. J. (1989). Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11, 954-963.
21. Vilar, F. J., Khoo, S. H. & Walley, T. (1999). The management of Pneumocystis carinii pneumonia. Br J Clin Pharmacol 47, 605-609.
22. WHO (1999). STI/HIV: Status and Trends of STI, HIV and AIDS at the End of the Millennium. Western Pacific Region 1999. Manila: World Health Organization, Regional Office for the Western Pacific.
23. Wong, K. H., Lee, S. S., Low, K. H. & Wan, W. Y. (2003). Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality. AIDS Patient Care STDS 17, 461-469.